Inventor · disambiguated record
Alexander Flohr
Also filed as: FLOHR ALEXANDER
56 granted patents·17 pending applications·371 citations·filing 2001–2024
98Inventor score
Files withHOFFMANN LA ROCHE47BLACK DIAMOND THERAPEUTICS INC5MONTE ROSA THERAPEUTICS INC5ALANINE ALEXANDER3BAUMANN KARLHEINZ2
Top patents by PatentIndex Score
73 records- 0195US6521754B2Benzothiazole derivatives with activity as adenosine receptor ligandsHOFFMANN LA ROCHE·Filed 2001·Granted Feb 18, 2003·53 cites·12 claims
- 0290US6596718B17-Morpholin-4yl-benzothiazole amide derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Jul 22, 2003·43 cites·16 claims
- 0389US6620811B2Isonicotin- and nicotinamide derivatives of benzothiazolesHOFFMANN LA ROCHE·Filed 2002·Granted Sep 16, 2003·36 cites·43 claims
- 0488US11912682B2Isoindolinone compoundsMONTE ROSA THERAPEUTICS INC·Filed 2023·Granted Feb 27, 2024·2 cites·7 claims
- 0588US7368446B24-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amideHOFFMANN LA ROCHE·Filed 2005·Granted May 6, 2008·14 cites·9 claims
- 0688US6963000B2Benzothiazole derivatives with activity as adenosine receptor ligandsHOFFMANN LA ROCHE·Filed 2002·Granted Nov 8, 2005·20 cites·24 claims
- 0788US6727247B2Substituted benzothiazole amide derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Apr 27, 2004·27 cites·5 claims
- 0887US7544679B26-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivativesHOFFMANN LA ROCHE·Filed 2008·Granted Jun 9, 2009·9 cites·6 claims
- 0986US7317007B2Benzothiazole derivatives with activity as adenosine receptor ligandsHOFFMANN LA ROCHE·Filed 2005·Granted Jan 8, 2008·5 cites·9 claims
- 1086US6599901B1Pyridone substituted benzothiazole derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Jul 29, 2003·24 cites·21 claims
- 1185US11034672B1Tyrosine kinase inhibitor compositions, methods of making and methods of useBLACK DIAMOND THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·2 cites·29 claims
- 1285US8349824B2Triazolopyridine compoundsHOFFMANN LA ROCHE·Filed 2011·Granted Jan 8, 2013·9 cites·26 claims
- 1385US7160875B2Malonamide derivativesHOFFMANN LA RACHE INC·Filed 2004·Granted Jan 9, 2007·31 cites·24 claims
- 1483US9394311B2Triazolo compounds as PDE10 inhibitorsHOFFMANN LA ROCHE·Filed 2014·Granted Jul 19, 2016·7 cites·9 claims
- 1583US6835732B2Benzothiazole derivatives with activity as adenosine receptor ligandsHOFFMANN LA ROCHE·Filed 2002·Granted Dec 28, 2004·11 cites·18 claims
- 1682US7923450B2Modulators for amyloid betaHOFFMANN LA ROCHE·Filed 2009·Granted Apr 12, 2011·6 cites·14 claims
- 1779US8962834B2Modulators of amyloid betaHOFFMANN LA ROCHE·Filed 2013·Granted Feb 24, 2015·4 cites·11 claims
- 1879US7414049B24-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Aug 19, 2008·2 cites·8 claims
- 1977US8263584B2ImidazopyridinesALBERATI DANIELA·Filed 2011·Granted Sep 11, 2012·4 cites·18 claims
- 2076US8486967B2Heteroaryl substituted piperidinesBAUMANN KARLHEINZ·Filed 2011·Granted Jul 16, 2013·4 cites·8 claims
- 2176US8017604B2ImidazopyridinesHOFFMANN LA ROCHE·Filed 2010·Granted Sep 13, 2011·3 cites·29 claims
- 2276US7425551B2Malonamide derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Sep 16, 2008·2 cites·10 claims
- 2376US7371749B2Benzothiazole derivativesHOFFMANN LA ROCHE·Filed 2005·Granted May 13, 2008·2 cites·14 claims
- 2476US7166587B2Carbamic acid alkyl ester derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Jan 23, 2007·9 cites·27 claims
- 2575US6713499B27-Amino-benzothiazole derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Mar 30, 2004·8 cites·17 claims
- 2674US11633488B2Modified IL-2 polypeptides and uses thereofBRIGHT PEAK THERAPEUTICS AG·Filed 2021·Granted Apr 25, 2023·1 cites·20 claims
- 2774US8772510B2PDE10 modulatorsBACHMANN STEPHAN·Filed 2012·Granted Jul 8, 2014·3 cites·25 claims
- 2873US7019001B2Substituted benzothiazole amide derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Mar 28, 2006·5 cites·9 claims
- 2973US6734179B2BenzothiazolesHOFFMANN LA ROCHE·Filed 2002·Granted May 11, 2004·6 cites·23 claims
- 3071US12391663B2Isoindolinone compoundsMONTE ROSA THERAPEUTICS AG·Filed 2023·Granted Aug 19, 2025·0 cites·20 claims
- 3170US8410117B2Imidazopyrimidine derivativesALVAREZ SANCHEZ RUBEN·Filed 2011·Granted Apr 2, 2013·4 cites·26 claims
- 3270US2010075959A1Benzothiazole derivatives with activity as adenosine receptor ligandsALANINE ALEXANDER·Filed 2009·Application pending·0 cites
- 3368US6730670B27-phenyl-benzo[b]thiophen amide derivativesHOFFMANN LA ROCHE·Filed 2002·Granted May 4, 2004·3 cites·16 claims
- 3467US7371748B2Benzothiazole derivativesHOFFMANN LA ROCHE·Filed 2004·Granted May 13, 2008·3 cites·16 claims
- 3566US8703768B2Nitrogen containing heteroaryl compoundsBLEICHER KONRAD·Filed 2011·Granted Apr 22, 2014·2 cites·55 claims
- 3666US7285548B2Urea substituted benzothiazolesHOFFMANN LA ROCHE·Filed 2004·Granted Oct 23, 2007·2 cites·10 claims
- 3766US6624163B2Benzothiazole derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Sep 23, 2003·2 cites·16 claims
- 3865US2008108809A1Benzothiazole derivatives with activity as adenosine receptor ligandsALANINE ALEXANDER·Filed 2007·Application pending·0 cites
- 3965US2008125419A1Benzothiazole derivatives with activity as adenosine receptor ligandsALANINE ALEXANDER·Filed 2007·Application pending·0 cites
- 4064US8470820B2Nitrogen-containing heteroaryl derivativesBLEICHER KONRAD·Filed 2011·Granted Jun 25, 2013·1 cites·18 claims
- 4163US7304058B2Carbamic acid esters of benzothiazolesHOFFMANN LA ROCHE·Filed 2004·Granted Dec 4, 2007·1 cites·19 claims
- 4263US7122545B2Imidazo-benzothiazolesHOFFMANN LA ROCHE·Filed 2004·Granted Oct 17, 2006·1 cites·20 claims
- 4360US2005026906A1Benzothiazole derivatives with actitvity as adenosine receptor ligandsFiled 2004·Application pending·0 cites
- 4459US2024051936A1Isoindolinone compoundsMONTE ROSA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4559US2024051937A1Isoindolinone amide compounds useful to treat diseases associated with gspt1MONTE ROSA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4658US2022363666A1Tyrosine kinase inhibitor compositions, methods of making and methods of useBLACK DIAMOND THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4757US2024308976A1Compounds that mediate protein degradation and uses thereofMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4857US2024294495A1Compounds that mediate protein degradation and methods of use thereofMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4956US12435046B2Alkynyl quinazoline compoundsBLACK DIAMOND THERAPEUTICS INC·Filed 2020·Granted Oct 7, 2025·0 cites·20 claims
- 5056US2009215759A1Modulators for amyloid betaBAUMANN KARLHEINZ·Filed 2009·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Alexander Flohr files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →